DiscovHER PAN-206: Phase 2 tumour-agnostic study of Zanidatamab in patients with previously treated human epidermal growth factor receptor 2 (HER2)-overexpressing solid tumours. - Subbiah, Vivek; Makker, Vicky; Oh, Do-Youn; Gardener, Elizabeth; Gartner, Elaina; Meric-Bernstam, Funda (Gynecologic Oncology, 2026)